🇺🇸 FDA
Patent

US 10053494

Chemically activated nanocapsid functionalized for cancer targeting

granted A61KA61K2039/5258A61K9/5169

Quick answer

US patent 10053494 (Chemically activated nanocapsid functionalized for cancer targeting) held by The Regents of the University of California expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5258, A61K9/5169, A61P, A61P37/04